Skip to main content

Mesothelioma, In the US a new Orphan Drug for the Treatment of Neoplasia

It is BAY 94-9343, an experimental anticancer agent

A new orphan drug for the treatment of mesothelioma. It is BAY 94-9343, an experimental anticancer agent produced by Bayer HealthCare, which has obtained the status of an orphan drug by the Food and Drug Administration. It is an experimental drug currently in clinical development.

The drug is an ADC (in drug conjugated antibodies) that combines the targeting properties of an antibody with the effect cellular destruction of a small and powerful molecule of the cytotoxic agent.

BAY 94-9343 (mesothelin-ADC) is an antibody-conjugated drug that targets mesothelin, molecule highly expressed in mesothelioma. It is a drug that ultilzza an entity fully human antibody, generated thanks to the technology of HuCAL Morphos Platform.

The drug has been shown to have a powerful and targeted anti-cancer activity in preclinical studies.

In September 2011 it has started patient enrollment for a Phase I open-label to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of the drug. Patients are currently treated with BAY 94-9343 at three research centers in the United States (Maryland, Tennessee and Texas). For more information on this study (NCT01439152), you can visit the website www.clinicaltrials.gov.

"This is an important step in the development process of this investigational drug," said Prof. Andreas Busch, member of the Bayer HealthCare Executive Committee and Head of Global Drug Discovery. "Malignant mesothelioma is a rare type of cancer with a poor prognosis. C 'is a significant unmet medical need for these patients. Bayer therefore undertook to develop a therapy that can help people with this cancer to live longer longer, improving the quality of their lives. "

Recall that mesothelioma is a rare tumor, which represents less than 1 percent of all cancers. It develops from the cells of the mesothelium, the thin protective membrane that surrounds the large serous cavities of the human body. Malignant pleural mesothelioma is the most common form of mesothelioma.
Labels:

Comments

Post a Comment

Popular posts from this blog

General Information about Malignant Mesothelioma

Malignant mesothelioma is a disease in which malignant (cancerous) cells form in the lining of the chest or abdomen. Malignant mesothelioma is a disease in which malignant (cancer) cells are found in the pleura (the thin layer of tissue that lines the chest cavity and covers the lungs) or the peritoneum (the thin layer of tissue that lines the abdomen and covers most of the organs of the abdomen). Malignant mesothelioma can form in the heart or testicles, but this is not common Exposure to asbestos can influence the risk of malignant mesothelioma. Anything that increases the risk of getting a disease is called a risk factor. Having a risk factor does not mean you are going to have cancer; Having no risk factors does not mean you will not have cancer. Talk to your doctor if you think you may be at risk. Most people with malignant mesothelioma have worked or lived in places where they inhaled or swallowed asbestos. After exposure to asbestos, it usually takes a lon...
1 comment
Read more

Clinical-Radiological Markers of Exposure to Asbestos

There is some confusion about the criteria for exposure to asbestos. In the accreditation of the asbestos exposure there are 3 criteria that in order of importance are: 1.- the work history 2.- the exposure markers. 3.- The detection of asbestos bodies in biological samples. When there is a clear history of exposure to asbestos, as is the work activity in the different industrial sectors in which asbestos has been present, exposure to asbestos is sufficiently proven. The second criterion in importance is the existence of exposure markers. In this sense, clinical-radiological markers such as pleural plaques, diffuse pleural fibrosis and round atelectasis guarantee exposure to asbestos in a high proportion of cases, which reaches 81% -89% in round atelectasis (1). Finally, and contrary to what might appear, the negativity in the detection of asbestos bodies in biological samples does not exclude exposure to asbestos when one of the 2 major criteria is present: the work history and / or ...
Post a Comment
Read more

Mesothelioma Treatment

Mesothelioma treatment depends on the stage of the disease is, and you can tell that there is no standard treatments because of the smallness of their impact. The following therapies are currently used: Surgery Surgery with curative intent is, in theory, the best choice for the treatment of mesothelioma, however, complete resection (with large and negative margins) is rarely achieved. Less than 25% of the operated patients remain alive at 5 years. We have the following options:   Extrapleural pneumonectomy: is bloc resection of the parietal pleura and visceral, along with the lung infiltrated by the tumor, mediastinal lymph nodes, diaphragm and pericardium. All this is reconstructed meshes. It is a very complicated technique that is not done in all centers and having a high perioperative morbidity and mortality (in highly selected cases and expert hands is 4%). It has an average survival between 9 and 19 months and a survival rate at two years between 9...
1 comment
Read more